GS-7977 With Ribavirin for Hepatitis C (SPARE)

NCT01441180 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: GS7977
DRUG: RBV

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)